药物生物利用度
Drug Bioavailability
作者信息
Price Gary, Patel Deven A.
机构信息
University of Tennessee Health Science Center
Mercer University College of Pharmacy
PMID:32496732
Abstract
Bioavailability refers to the extent a substance or drug becomes completely available to its intended biological destination(s). More accurately, bioavailability is a measure of the rate and fraction of the initial dose of a drug that successfully reaches either; the site of action or the bodily fluid domain from which the drug's intended targets have unimpeded access.
摘要
生物利用度是指一种物质或药物到达其预期生物靶点的完全可用程度。更准确地说，生物利用度是衡量药物初始剂量成功到达以下两者之一的速率和比例：作用部位或药物预期靶点能够无障碍获取药物的体液区域。
相似文献
2
Network predicting drug's anatomical therapeutic chemical code.网络预测药物的解剖治疗化学编码。
Bioinformatics. 2013 May 15;29(10):1317-24. doi: 10.1093/bioinformatics/btt158. Epub 2013 Apr 5.
3
Polymers Enhancing Bioavailability in Drug Delivery.聚合物在药物递送中提高生物利用度
Pharmaceutics. 2022 Oct 16;14(10):2199. doi: 10.3390/pharmaceutics14102199.
4
A Recent Review on Bio-availability Enhancement of Poorly Water-soluble Drugs by using Bioenhancer and Nanoparticulate Drug Delivery System.近年来通过生物增强剂和纳米药物传递系统提高难溶性药物生物利用度的研究进展。
Curr Pharm Des. 2022;28(39):3212-3224. doi: 10.2174/1381612829666221021152354.
5
[Modulation of in vivo fate of drugs: fundamental biopharmaceutical and pharmacokinetic aspects].[药物体内命运的调控：基础生物药剂学和药代动力学方面]
Ann Pharm Fr. 2001 Jul;59(4):219-26.
6
Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.口服抗癌药物：低生物利用度的机制与改善策略。
Clin Pharmacokinet. 2013 Jun;52(6):399-414. doi: 10.1007/s40262-013-0040-2.
7
Methods for the comparative evaluation of pharmaceuticals.药物的比较评估方法。
GMS Health Technol Assess. 2005 Nov 15;1:Doc09.
8
Revealing Changes in Celecoxib Nanostructured Lipid Carrier's Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS.采用高效液相色谱-串联质谱法研究透明质酸作为增溶剂对塞来昔布纳米脂质载体生物利用度的影响。
Drug Des Devel Ther. 2024 Jul 29;18:3315-3327. doi: 10.2147/DDDT.S461969. eCollection 2024.
9
The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans.饮食、衰老和疾病状态对人体首过消除及口服药物生物利用度的影响。
Adv Drug Deliv Rev. 1997 Sep 15;27(2-3):129-159. doi: 10.1016/s0169-409x(97)00040-9.
10
Commercial health plans use of patient subgroup restrictions: An analysis of orphan and US Food and Drug Administration-expedited programs.商业健康计划对患者亚组的限制使用：对孤儿药和美国食品和药物管理局加速审批项目的分析。
J Manag Care Spec Pharm. 2023 May;29(5):472-479. doi: 10.18553/jmcp.2023.22363. Epub 2023 Mar 2.
Zotero 插件